Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ANYCARE LLC

NPI: 1780022855 · LEBANON, TN 37087 · Clinic/Center · NPI assigned 06/11/2013

$2.41M
Total Medicaid Paid
80,391
Total Claims
65,352
Beneficiaries
21
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialROBERTSON, GEORGE (OWNER/ URGENT CARE PHYSICIAN)
NPI Enumeration Date06/11/2013

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 9,428 $294K
2019 11,646 $285K
2020 6,976 $244K
2021 9,636 $394K
2022 14,945 $423K
2023 16,639 $464K
2024 11,121 $312K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 21,171 18,648 $1.05M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 11,711 10,897 $470K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 6,922 6,551 $240K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 18,204 8,475 $171K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 2,501 2,351 $137K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 12,109 11,306 $95K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 1,259 1,181 $93K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 2,151 2,023 $63K
87428 433 422 $23K
M0244 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency 40 29 $19K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 431 409 $17K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 52 30 $15K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 281 260 $11K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 173 169 $8K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 693 578 $5K
81003 1,929 1,766 $3K
86328 39 38 $1K
85027 177 151 $381.34
J1040 Injection, methylprednisolone acetate, 80 mg 14 13 $144.22
90756 12 12 $50.00
Q0240 Injection, casirivimab and imdevimab, 600 mg 89 43 $0.00